High-Output Jejunostomy After Massive Small Bowel Resection: Why 1,900 kcal Is Not Enough
Mr. K, 45, is three weeks out from resection of all but 90 cm of jejunum for superior mesenteric artery thrombosis. The ileum, ileocecal valve and entire colon were removed, and he has an end jejunostomy. He weighs 58 kg (usual 76 kg, height 178 cm). Stoma output is 2.6–3.0 L/day and he is passing about 400 mL of urine per day. He is on a two-in-one parenteral nutrition bag of 2.2 L/day delivering 1,900 kcal, 85 g amino acids and 60 g lipid, plus multivitamins and 70 mEq of sodium chloride. He continues to lose about 0.5 kg per week. Laboratory values: sodium 127 mEq/L, potassium 3.1 mEq/L, magnesium 1.3 mg/dL, bicarbonate 17 mEq/L, creatinine 1.1 mg/dL, albumin 2.8 g/dL, triglycerides 110 mg/dL. He is sipping 600 mL of plain water daily and asks for more because he is thirsty. He is on no antidiarrheal medication.
1. Explain why he remains volume-depleted and losing weight despite 1,900 kcal, and rewrite the fluid, sodium and electrolyte components of his parenteral regimen.
Read the worked answer
The caloric number is a distraction. With an end jejunostomy he loses sodium-rich, bicarbonate-rich fluid - roughly 100–140 mEq of sodium per litre of stoma output, so 2.6–3.0 L/day means 300–400 mEq of sodium leaving daily, against only 70 mEq supplied. He is sodium- and volume-depleted, and the resulting ADH-driven water retention plus his 600 mL of plain water produces hypotonic hyponatremia (127). The weight loss is largely volume, not fat, and the low creatinine partly reflects low muscle mass.
Revised parenteral components
- Sodium: 2–4 mEq/kg/day, about 120–230 mEq/day, given as sodium chloride with enough acetate to close the bicarbonate gap; bicarbonate 17 mEq/L justifies 40–60 mEq of acetate.
- Volume: match stoma output plus urine plus insensible losses, typically 2.5–3.5 L/day; concentrate the bag if fluid tolerance is the limit.
- Potassium and magnesium: 60–100 mEq potassium and additional magnesium (jejunostomy losses are magnesium-rich); low magnesium perpetuates hypokalemia.
- Energy and protein: 25–30 kcal/kg ideal body weight (73 kg → 1,800–2,200 kcal, plus an allowance for malabsorption) and 1.2–1.5 g/kg ideal body weight ≈ 90–110 g amino acids; lipid up to 1 g/kg/day is safe because there is no colon (no oxalate concern).
- Reassess weight only after sodium and volume are corrected; the current 58 kg is not a reliable guide.
2. What oral intake strategy and antidiarrheal plan do you recommend, and how would you advance enteral feeding?
Read the worked answer
Oral strategy
- Stop plain water; it washes straight out and drags sodium with it, worsening hyponatremia. Replace it with a high-sodium oral rehydration solution (sodium 90–120 mEq/L is generally needed in short bowel; standard sports drinks at 20–25 mEq/L are inadequate).
- Small, frequent meals with a starch and protein at each sitting; avoid hypertonic juices, sweets and rapid drinking with meals; separate fluids from solids initially.
- Build a food-and-output diary so interventions can be judged by stoma volume rather than impression.
Antidiarrheal plan
- Loperamide 2–4 mg before meals and at bedtime, titrated up to a maximum around 16 mg/day.
- Add diphenoxylate-atropine or codeine if output remains high; give antimotility agents 30–60 minutes before meals so they are active when food arrives.
- Proton pump inhibitor to reduce gastric hypersecretion, which is common after massive resection and contributes to output; consider octreotide if output persistently exceeds 3 L/day.
Enteral advancement
- Begin trophic continuous feeding alongside parenteral nutrition and advance slowly; jejunostomy feeding is compatible with a low-fat or peptide-based formula if a polymeric formula is poorly tolerated. Enteral stimulation is what drives intestinal adaptation, so it should start even while parenteral nutrition supplies the bulk of nutrition.
3. He asks whether a drug could get him off parenteral nutrition. What is your answer, including prerequisites and realistic expectations?
Read the worked answer
The drug he is asking about is likely teduglutide, a glucagon-like peptide-2 analogue given as 0.05 mg/kg subcutaneously once daily. It is a reasonable long-term conversation but not a rapid fix, and he needs candid expectations.
Prerequisites and caveats
- He must be stabilized first: sodium, magnesium and volume corrected, antidiarrheals optimized, and a structured intestinal rehabilitation program in place. Starting teduglutide on top of a sodium-depleted patient confuses attribution of any improvement.
- The medication is indicated for parenteral-nutrition-dependent short bowel syndrome, typically after a period of adaptation and after resection has stabilized; it is contraindicated with active malignancy and requires review for active obstruction and, in patients with colon in continuity, surveillance colonoscopy.
- It is expensive, injectable, and requires commitment to monitoring.
Realistic expectations
- Trials and practice show roughly a 20–30% reduction in parenteral volume and some patients achieving days off parenteral nutrition; complete independence is possible but not typical in a patient with 90 cm of jejunum, no ileum and no colon.
- Restored absorption can cause fluid overload and rapid shifts; watch weight, urine output and sodium closely after initiation.
Frame it as one component of adaptation - alongside enteral stimulation, antidiarrheals, high-sodium oral rehydration and dietitian follow-up - not as a substitute for them.